vimarsana.com
Home
Live Updates
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer : vimarsana.com
MaxCyte Appoints Douglas Swirsky as Chief Financial Officer
ROCKVILLE, Md., March 27, 2023 -- MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization... | March 27, 2023
Related Keywords
United Kingdom ,
Douglasj Swirsky ,
Mary Jane Elliott ,
Ron Holtz ,
David Deuchler ,
Rupert Dearden ,
Panmure Gordon ,
Chris Welsh ,
Doug Doerfler ,
Douglas Swirsky ,
Emma Earl Freddy Crossley ,
Board Of Cellectar Biosciences Inc ,
Aavantibio Inc ,
Exchange Commission On ,
Maxcyte Inc ,
Nasdaq ,
Consilium Strategic Communications ,
Rexahn Pharmaceuticals Inc ,
Gilmartin Group ,
Morgan Stanley ,
Business Administration ,
Linkedin ,
Legg Mason ,
Twitter ,
Solid Biosciences Inc ,
Genvec Inc ,
Administration For The Company ,
Exchange Commission ,
Kellogg School Of Management At Northwestern University ,
Boston University ,
Chief Financial Officer ,
Solid Biosciences ,
Interim President ,
Chief Executive Officer ,
Rexahn Pharmaceuticals ,
Chief Financial ,
Managing Director ,
Life Sciences Investment Banking ,
Stifel Nicolaus ,
Cellectar Biosciences ,
Kellogg School ,
Chief Accounting Officer ,
Private Securities Litigation Reform Act ,
Annual Report ,
Cyte Contacts ,
Joint Corporate ,
Maxcyte ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Arch ,
023 ,
Ocused ,
Company ,
Roviding ,
Nabling ,
Platform ,
Technologies ,
O ,
Advance ,
The ,
Development ,
Nd Mxct Us57777k1060 ,
vimarsana.com © 2020. All Rights Reserved.